London-listed stocks pushed higher by Tuesday lunchtime, though gains were limited with no major economic data or corporate ...

Wall Street futures had major indices reclaiming some of yesterday's losses as markets remain volatile following the ...

Swiss healthcare giant Roche announced on Tuesday that it is planning to spend $50bn in pharmaceuticals and diagnostics in ...

Hutchmed China announced on Tuesday that it has completed patient enrollment for the registration phase of its phase two ...

Orosur Mining announced the issue of 83,333 new shares on Tuesday, following the exercise of stock options by a company ...

Pharmacitucal firm Shield Therapeutics said on Tuesday that it had inked an exclusive licence agreement for its ACCRUFeR iron ...

Drugmaker AstraZeneca said on Tuesday that it had received "positive high-level results" from a Phase III trial on its ...

The financial newswire headlines are covered in various iterations of 'sell the US' but stocks in London and over on the ...

Data solutions provider Celebrus Technologies warned on Tuesday that FY25 revenues were expected to fall short of ...

Analysts at Berenberg upgraded exploration and production outfit Energean from 'hold' to 'buy' on Tuesday, stating the group ...

Ricardo said in an update on Tuesday that it expects to deliver financial performance for the 2024-2025 financial year within ...

Helium One Global reported encouraging flow test results from the Jackson-29 well at the Galactica Project in Colorado on ...